Braden Michael Leonard - Sep 12, 2024 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (RPHM)

Role
10%+ Owner
Signature
Braden Michael Leonard
Stock symbol
RPHM
Transactions as of
Sep 12, 2024
Transactions value $
$484,344
Form type
4
Date filed
9/16/2024, 04:15 PM
Previous filing
Sep 9, 2024
Next filing
Sep 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPHM Common Stock Purchase $50.5K +36.2K +1.23% $1.40 2.98M Sep 12, 2024 Holding of BML Investment Partners, L.P. F1, F2
transaction RPHM Common Stock Purchase $197K +150K +5.03% $1.31 3.13M Sep 13, 2024 Holding of BML Investment Partners, L.P. F1, F3
transaction RPHM Common Stock Purchase $237K +173K +5.52% $1.37 3.3M Sep 16, 2024 Holding of BML Investment Partners, L.P. F1, F4
holding RPHM Common Stock 1.02M Sep 12, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
F2 Purchased in multiple transactions with a weighted average price of $1.3966. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
F3 Purchased in multiple transactions with a weighted average price of $1.313. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
F4 Purchased in multiple transactions with a weighted average price of $1.3712. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.